APO-AMITRIPTYLINE Tablets recall in Canada: Contamination risk
In plain language
This recall involves APO-AMITRIPTYLINE Tablets sold in Canada. They are being recalled because they contain an impurity (NNORT) above acceptable limits. Consult your healthcare provider before stopping use and for any health concerns.
What to do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use.
- Contact Apotex Inc. if you have questions.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
APO-AMITRIPTYLINE 10 mg
Lot: PY1833, RM0518
APO-AMITRIPTYLINE 25 mg
Lot: PV0569
Why this matters
Contamination risk
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the lot number
Lot numbers identify specific production batches.
Affected lots: PV0569, PY1833, RM0518
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Contamination risk
What should consumers do?
Verify if your product is affected. Consult your healthcare provider prior to discontinuing use. Contact Apotex Inc. if you have questions.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Contamination risk
When was this product recalled?
This product was recalled on August 14, 2023.
Is the APO-AMITRIPTYLINE brand affected by this recall?
Yes, APO-AMITRIPTYLINE products are affected by this recall. This recall involves APO-AMITRIPTYLINE Tablets sold in Canada. They are being recalled because they contain an impurity (NNORT) above acceptable limits. Consult your healthcare provider before stopping use and for any health concerns.